(NasdaqGM:SEPN), Advancing Selection of Next-Generation Oral Small Molecule PTH1R Agonist for Clinical Development Initiating Phase 1 Trial for SEP-631, MRGPRX2 NAM Program, for Mast Cell Diseases Updated Cash Runway Expected to Support Operating Plans at Least into 2029 SOUTH SAN FRANCISCO, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) — Septerna, Inc. (Nasdaq: SEPN), a biotechnology company […]
(NASDAQ:GYRE), Net income of $1.6 million and $5.3 million for the three and six months ended June 30, 2025, respectively; reaffirms full-year revenue guidance of $118-128 million Ping Zhang, Executive Chairman, appointed interim CEO as Dr. Han Ying transitions to scientific leadership role Revenue of $26.8 million and $48.8 million for the three and six
(NASDAQ:PLUG), • Execution on Project Quantum Leap helps accelerate business salesgrowth and financial performance• Q2 revenue up 21% year-over-year, driven by broad hydrogen demand LATHAM, N.Y., Aug. 11, 2025 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, today announced its financial results and operational
(NASDAQ:GEVO), Achieves Positive Net Income in the Second Quarter and Positive Adjusted EBITDA1 for the Second Quarter and Six Months Ended June 30, 2025 Positive Net Income Attributable to Gevo of $2.1 million in the Second Quarter Positive Adjusted EBITDA1 of $17 million in the Second Quarter Revenues Increased $14 million Quarter-Over-Quarter Positive Earnings per
Standard BioTools Reports Second Quarter 2025 Financial Results GlobeNewswire August 11, 2025 SOUTH SAN FRANCISCO, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) — Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the second quarter ended June 30, 2025. Standard BioTools will no longer host its second quarter 2025 earnings
(NasdaqGM:USAR),(NasdaqGM:USARW), STILLWATER, Okla., Aug. 11, 2025 (GLOBE NEWSWIRE) — USA Rare Earth, Inc. (Nasdaq: USAR) (“USAR” or the “Company”) today announced its financial and operational results for the second quarter and six months ended June 30, 2025. Second Quarter Highlights Stillwater, Oklahoma magnet facility on track for 1Q26 commissioning. 12 MOUs and JDAs signed to
(NasdaqGM:RPD), BOSTON, Aug. 11, 2025 (GLOBE NEWSWIRE) — Rapid7, Inc. (NASDAQ: RPD), a leader in threat detection and exposure management, today announced that the company will be attending the following conferences: The Canaccord Genuity 45th Annual Growth Conference in Boston, MA. The presentation is scheduled for Tuesday, August 12, 2025 at 9:30 a.m. Eastern Time.
Xenon Reports Second Quarter 2025 Financial Results & Business Update GlobeNewswire August 11, 2025 – Phase 3 azetukalner X-TOLE2 FOS study patient recruitment complete, with topline data anticipated in early 2026– Phase 3 azetukalner neuropsychiatric studies underway with X-NOVA3 in MDD and X-CEED in BPD recently initiated– Phase 1 healthy volunteer study initiated for lead
(NASDAQ:MFIC), Results for the Quarter Ended June 30, 2025 and Other Recent Highlights: Net investment income per share for the quarter was $0.39, compared to $0.37 for the quarter ended March 31, 2025 Net asset value per share as of the end of the quarter was $14.75, compared to $14.93 as of March 31, 2025,
Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial Results GlobeNewswire August 11, 2025 Advancing Selection of Next-Generation Oral Small Molecule PTH1R Agonist for Clinical Development Initiating Phase 1 Trial for SEP-631, MRGPRX2 NAM Program, for Mast Cell Diseases Updated Cash Runway Expected to Support Operating Plans at Least into 2029 SOUTH SAN FRANCISCO,